Moreover, and in contrast to MCL, CD24 antibody treatment of the DLBCL cell line panel induced lower levels of phagocytosis than treatment with CD47 mAb InhibRx in most cell lines, with the exception of SU-DHL-6 (Figure 4B). Here, CD47 is linked to diffuse large B-cell lymphoma.